Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33917224

about

Neoantigen-based cancer immunotherapy Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment The next steps in next-gen sequencing of cancer genomes Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies Update on immune checkpoint inhibitors in gynecological cancers Tumor neoantigens: building a framework for personalized cancer immunotherapy Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection Identification of trunk mutations in gastric carcinoma: a case study Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity.Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.Neoantigens in cancer immunotherapy.Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.Haematological malignancies: at the forefront of immunotherapeutic innovation.Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era.MuPeXI: prediction of neo-epitopes from tumor sequencing data.pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma Molecular and genetic properties of tumors associated with local immune cytolytic activity.A Tumor-Specific Neo-Antigen Caused by a Frameshift Mutation in BAP1 Is a Potential Personalized Biomarker in Malignant Peritoneal Mesothelioma Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.Designer vaccine nanodiscs for personalized cancer immunotherapy.Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.Therapeutic targeting of tumor suppressor genes Synthetic biology in cell-based cancer immunotherapy.The neoepitope landscape in pediatric cancers.An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.

P2860

Q26738693-4F8825C0-3FF8-44C5-91AB-573C650C2A9B Q26744758-7065ADA7-E81F-4583-BC64-83EFB4F2E305 Q26783055-DEEEB8E0-1C2C-40CC-95D5-838CC250F9EA Q26998894-22E0131E-DB75-4CC1-ABA8-3BFC0C4FEFC0 Q27310763-1D31EE9F-3E19-4E82-9831-5B19938D37C1 Q28067817-E0EA3907-E922-41B4-BDFF-481F4C7502B7 Q28076497-1D973A0B-7631-444B-A7B4-8060707E78D3 Q28082704-A7E63357-12A2-4545-892D-FBEAD201E203 Q29615679-E1DA5E59-511C-4C4F-9A2C-929F7A29B911 Q31117752-5295F2E0-166E-4F6C-B1A2-F6FCE3D905D5 Q33630241-321EFAA2-11DB-4A0C-8641-C78230C13F7F Q33921459-B1539FCD-A88E-493F-A6CD-8B7D432B554A Q34375163-01CD76BB-115F-40FA-918C-CFA0FA901FE7 Q34398369-DB086C75-B628-4B30-81E2-90B530542C37 Q34470074-1FDDC253-8715-48F7-83EC-0AB119E07736 Q35799065-503DFA54-D930-4E12-9630-CAEB04D4621D Q35880618-DF6DBAF5-61B0-45DD-A68C-DFDCAB68A1E7 Q35909370-FF03978D-3C70-4B87-AE54-6F3D990F9702 Q36021163-E0F64D38-9477-47FB-AC70-CD7FDD6776FE Q36024656-4F6ED68D-75BE-4C53-8DF8-33CF79262D17 Q36188919-505D8B02-C9AE-4FD8-9263-49233F32E4BA Q36316627-76A9E4A2-E541-4990-B439-ECF11B3C8678 Q36352986-A9B92327-41F1-4253-9940-964EE44A1B74 Q36521595-35544C14-FD03-4731-858F-5C7547ADAD4A Q36553815-E79AD850-6AF7-4FEC-8360-530D32D1439C Q36850230-2A2FFF41-C097-404D-AD47-5C2BDE193624 Q36869059-C5049C4E-FE56-4FB0-BA0A-6BA8114ED8CD Q36939300-687AB056-686C-412F-983A-4C795D19C07C Q37046405-559B9BBB-450C-4522-81E9-8957C3C72FC7 Q37193493-1A29DFC4-3D54-4E98-9702-B0701BEAD221 Q37370230-2C9B701B-C466-494F-A665-90CEF29A7431 Q37457945-A8B16BC0-7D9C-4158-80D9-1E52FB242C3B Q37517482-51D4A72C-BDA6-45DB-929B-0304A98EDD78 Q37587362-6E4729A6-2DC8-4F04-AC87-53D0A7178974 Q37730767-A2344838-0B31-4306-90C3-AB9EACEEEAAE Q38244094-EC23710D-314A-4D7B-BC0B-E73384F8A20B Q38306663-7ACEDF10-76EB-42B2-9292-7DD2FDE69AF4 Q38531361-49678542-38DE-4007-8419-AF0C75E2897B Q38601828-F3A1C781-0F6B-4456-90C2-CD8C5C614CB8 Q38603909-8183F525-8BE4-451B-ACC9-025795D18CFE

P2860

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q33917224

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Systematic identification of p ...... chronic lymphocytic leukemia.

@ast

Systematic identification of p ...... chronic lymphocytic leukemia.

@en

type

label

Systematic identification of p ...... chronic lymphocytic leukemia.

@ast

Systematic identification of p ...... chronic lymphocytic leukemia.

@en

altLabel

Systematic identification of p ...... n chronic lymphocytic leukemia

@en

prefLabel

Systematic identification of p ...... chronic lymphocytic leukemia.

@ast

Systematic identification of p ...... chronic lymphocytic leukemia.

@en

P1433

Q33917224-A5E0993C-B90E-4A5D-BA3F-40E4722C061F

P1476

Q33917224-75A47D9D-8475-4D93-A009-5255BCD215CE

P2093

Q33917224-17BAE626-237A-4C8B-B458-621B3E0751A3

Q33917224-257DE479-26CF-48D4-8A57-9261FAD1D83C

Q33917224-2988E940-EB5A-41F5-A230-558848EF4EFD

Q33917224-2A2F1C8C-9FE5-4612-B258-043E13D76CC5

Q33917224-2E6922BA-E41D-4A18-92C7-32B847D475F7

Q33917224-7B6A35C5-D754-463C-BB9E-2EE2AF790EAA

Q33917224-C52CEA76-B4A8-44F6-B21D-0B6D6B5B302F

Q33917224-E1D307FA-4E4C-43D7-9998-BF00BFD3927A

Q33917224-E764C2F4-C562-4E1B-8307-6F10839CCDA2

Q33917224-F2681AE6-B8BB-4663-B389-57363DE1562A

P2860

Q33917224-052B21FA-2407-4C78-A4D8-F27126AD2355

Q33917224-0BBD5A66-3AD2-4EE6-B774-6BBFC902AFB9

Q33917224-1081E7DC-9423-46E3-92F3-53780A4D7ACF

Q33917224-11A00586-5B55-4045-99D8-6A7BCEC5424F

Q33917224-1D1A3DEC-CA8F-46D9-8524-2316BA500BCC

Q33917224-1D67B454-9E3F-448C-B013-9E154E71851A

Q33917224-21A70610-9A3D-4F47-BF8F-CA6B2E1B34A7

Q33917224-23BC5E61-76F0-4627-A875-4F62DD37AF29

Q33917224-2A7B8F4A-D700-4D53-8715-EC6AE7CB7F15

Q33917224-2AC28130-E615-41E1-9CD7-C15E26961A79

P304

Q33917224-19FD2D4C-2F70-434B-A4F3-9A4DC866BC25

P31

Q33917224-2469BBD5-1DB2-468E-BD0D-26D0EFB240C6

P356

Q33917224-2595C2BD-A10B-4DCC-920B-959735448DC8

P407

Q33917224-9F3FE201-AEC5-4758-AD25-317C93395823

P433

Q33917224-82592291-1D7F-40E7-9415-D5124EBBE043

P478

Q33917224-FEB9228B-C024-4AC6-978F-FD059E628317

P50

Q33917224-59718FEA-38DA-41D1-9CB1-A3AF4A52E890

Q33917224-5A4AE263-7427-440B-9DF8-FCE6E4AB5E24

Q33917224-8DAF062D-9D7A-4905-93B4-3155BF1AC413

Q33917224-A52A3181-AD78-4842-B262-FBC2C6A1143E

Q33917224-A7B2E789-2BA1-494E-B0AA-96986B37861D

Q33917224-B49D4C83-CC19-4D3B-BE61-381CD87E5DCB

Q33917224-C7EFAB89-692D-4532-98B6-E287D4E7CC7C

Q33917224-F6602A4D-20F5-48A9-B8A0-86511657C18D

P577

Q33917224-8699E84B-9ED3-415D-A348-543D22C20098

P5875

Q33917224-43C2CCAB-EC6C-4861-87F2-128527845E40

P698

Q33917224-7C44179B-13D5-45D7-96F3-4DFD0F151C5D

P921

Q33917224-5AF2B5CF-8789-4070-9C13-4ED1E80C3FDD

Q33917224-EEFB8EB5-6CD9-4613-85A1-F73C6491CDD6

P932

Q33917224-4017AFAB-EFE8-4A58-AF55-386F90D91809

P356

BLOOD-2014-04-567933

P1433

P1476

Systematic identification of p ...... chronic lymphocytic leukemia.

@en

P2093

Catherine J Wu

http://www.w3.org/2001/XMLSchema#string

David DeLuca

http://www.w3.org/2001/XMLSchema#string

Derin B Keskin

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Edward F Fritsch

http://www.w3.org/2001/XMLSchema#string

Ellese Carmona

http://www.w3.org/2001/XMLSchema#string

John Sidney

http://www.w3.org/2001/XMLSchema#string

Kristen Stevenson

http://www.w3.org/2001/XMLSchema#string

Mohini Rajasagi

http://www.w3.org/2001/XMLSchema#string

Sachet A Shukla

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Cloning of a novel protein interacting with BRS-3 and its effects in wound repair of bronchial epithelial cells

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Cancer immunotherapy: moving beyond current vaccines

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Alms1-disrupted mice recapitulate human Alström syndrome.

P304

453-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-04-567933

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Kristian Cibulskis

Vladimir Brusic

P577

2014-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262817338

http://www.w3.org/2001/XMLSchema#string

P698

24891321

http://www.w3.org/2001/XMLSchema#string

P921

P932

4102716

http://www.w3.org/2001/XMLSchema#string